255 related articles for article (PubMed ID: 36978408)
1. Medicinal Plants as Therapeutic Alternatives to Combat
Gautam S; Qureshi KA; Jameel Pasha SB; Dhanasekaran S; Aspatwar A; Parkkila S; Alanazi S; Atiya A; Khan MMU; Venugopal D
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978408
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
[TBL] [Abstract][Full Text] [Related]
4. Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant
Dehestani S; Davoodi J; Emami SA; Seddighinia FS; Sahebkar A; Soleimanpour S
Comb Chem High Throughput Screen; 2022; 25(5):870-876. PubMed ID: 33588723
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
Park HE; Lee W; Shin MK; Shin SJ
Front Immunol; 2021; 12():703060. PubMed ID: 34262571
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
8. Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis.
Catalão MJ; Filipe SR; Pimentel M
Front Microbiol; 2019; 10():190. PubMed ID: 30804921
[TBL] [Abstract][Full Text] [Related]
9. Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.
Martini MC; Zhang T; Williams JT; Abramovitch RB; Weathers PJ; Shell SS
J Ethnopharmacol; 2020 Nov; 262():113191. PubMed ID: 32730878
[TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the mTOR Pathway for Tuberculosis Treatment.
Singh P; Subbian S
Front Microbiol; 2018; 9():70. PubMed ID: 29441052
[TBL] [Abstract][Full Text] [Related]
12. Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals.
Fatima S; Kumari A; Dwivedi VP
MedComm (2020); 2021 Dec; 2(4):494-513. PubMed ID: 34977867
[TBL] [Abstract][Full Text] [Related]
13. Anti-mycobacteria potential and synergistic effects of combined crude extracts of selected medicinal plants used by Bapedi traditional healers to treat tuberculosis related symptoms in Limpopo Province, South Africa.
Komape NP; Bagla VP; Kabongo-Kayoka P; Masoko P
BMC Complement Altern Med; 2017 Feb; 17(1):128. PubMed ID: 28235402
[TBL] [Abstract][Full Text] [Related]
14. The Medicinal Chemistry of Chalcones as Anti-
Rodríguez-Silva CN; Prokopczyk IM; Dos Santos JL
Mini Rev Med Chem; 2022; 22(16):2068-2080. PubMed ID: 35156577
[TBL] [Abstract][Full Text] [Related]
15. A review of medicinal plant of Middle East and North Africa (MENA) region as source in tuberculosis drug discovery.
Dehyab AS; Bakar MFA; AlOmar MK; Sabran SF
Saudi J Biol Sci; 2020 Sep; 27(9):2457-2478. PubMed ID: 32884430
[TBL] [Abstract][Full Text] [Related]
16. Promising Antimycobacterial Activities of Flavonoids against
Rabaan AA; Alhumaid S; Albayat H; Alsaeed M; Alofi FS; Al-Howaidi MH; Turkistani SA; Alhajri SM; Alahmed HE; Alzahrani AB; Mashraqi MM; Alwarthan S; Alhajri M; Alshahrani FS; Almuthree SA; Alsubki RA; Abuzaid AA; Alfaresi M; Al Fares MA; Mutair AA
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014572
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Resistance to
Arrigoni R; Ballini A; Topi S; Bottalico L; Jirillo E; Santacroce L
Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290089
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
de Wet TJ; Warner DF; Mizrahi V
Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
